Ticker

No recent analyst price targets found for GTHP.

Latest News for GTHP

Guided Therapeutics Reaches Collaborative Agreement with Türkiye's Ministry of Health to Become Primary Screening Test for Cervical Cancer

PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced that it has reached an agreement with the Ministry of Health to co-develop LuViva for primary screening of cervical cancer in Türkiye. The first step of the collaborative agreement is to conduct an 800 patient clinical study to optimize LuViva's AI pattern recognition algorithms…

Business Wire • Sep 9, 2026
Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor

PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received a payment of $80,000 from distribution partner Hangzhou Dongye Medical Technology Company Ltd (HDMT). The payment is the fourth installment of a $700,000 purchase order the Company received from HDMT last year. The four LuViva devices are expected to…

Business Wire • Jul 22, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for GTHP.

No House trades found for GTHP.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top